Listed by the USPTO as VOKES, KATHLEEN PAIGE
Tech Center 3700 • Art Units: 3783
This examiner grants 56% of resolved cases
VOKES, KATHLEEN PAIGE is assigned to Tech Center 3700 and Art Unit 3783. The record shows 80 resolved cases, a 56.3% allowance rate, and a median of 1515 days to allowance. The interview lift is 27.5%, suggesting that direct examiner engagement may be useful, but the median timeline indicates that prosecution planning should also address delay.
The listed companies are Boston Scientific Corporation, Becton, Dickinson and Company, and Becton Dickinson France. The leading firms are Knobbe, Martens, Olson & Bear, LLP, Alliance IP, LLC - General, and Amsel IP Law PLLC. Because the resolved-case record is limited, practitioners should use the profile as a planning signal rather than a definitive prediction.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18383814 | Rapidly Insertable Central Catheters Including Catheter Assemblies and Methods Thereof | Final Rejection | Bard Access Systems, Inc. |
| 17889329 | DEVICES, SYSTEMS, AND METHODS FOR ACTIVATION OF A PHOTOACTIVE AGENT | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 17185685 | MEDICAL THERAPY SYSTEMS AND METHODS OF USING THE SAME | Final Rejection | Boston Scientific Scimed, Inc. |
| 18455747 | CATHETER ASSEMBLY | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18639864 | WEARABLE BIOELECTRONICS FOR PROGRAMMABLE DELIVERY OF THERAPY | Non-Final OA | The Regents of the University of California |
| 18659086 | ERECTOR SPINAE REGIONAL PAIN INDWELLING CATHETER DEVICE | Non-Final OA | VANDERBILT UNIVERSITY |
| 18455004 | Injection Needle with Surface Texture Modification and Method of Manufacturing Thereof | Final Rejection | Becton, Dickinson and Company |
| 17050321 | DELIVERY DEVICE AND ADSORBENT | Non-Final OA | Becton, Dickinson and Company |
| 18883710 | ADHESIVE PATCH AND SYSTEM FOR WEARABLE MEDICAL DEVICE | Non-Final OA | INSULET CORPORATION |
| 16968134 | INJECTOR AND METHOD OF INJECTING SOLUTION CONTAINING BIOMOLECULES INTO CELL NUCLEUS OF INJECTION TARGET USING THE SAME | Non-Final OA | DAICEL CORPORATION |
| 18469706 | Needle Arrangement | Final Rejection | Sanofi-Aventis Deutschland GMBH |
| 18561627 | Silicone Low Profile Port with Rigid Baseplate and Stem | Final Rejection | Bard Peripheral Vascular, Inc. |
| 17639940 | MEDICAL CONNECTOR WITH AUTOMATIC SEALING ON DISCONNECTION | Non-Final OA | Fresenius Medical Care Deutschland GmBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.3% of resolved applications examined by Kathleen Paige Vokes were allowed (80 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +27.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kathleen Paige Vokes took 1,515 days on average from filing to allowance.
Kathleen Paige Vokes examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
